Skip to main content

Vulnerable Pakistanis to get priority for Chinese COVID-19 vaccine


By Masood Sattar Khan
(Pakistan News & Features Services)

China will provide a coronavirus vaccine candidate developed by Sinopharm, a unit of the China National Pharmaceutical Group, to Pakistan as part of a trial agreement.

The University of Karachi and Sinopharm are set to collaborate on vaccine trials and Pakistan will get vaccine doses sufficient to vaccinate one-fifth of its population. 

According to reports, the initial doses will be used to vaccinate the most vulnerable among the Pakistani population including the elderly, healthcare workers and people with medical conditions associated with serious cases of COVID-19.

Earlier in April, Sinopharm had invited the National Institute of Health (NIH), Islamabad, to collaborate in conducting clinical trials of its inactivated vaccine for COVID-19 in Pakistan. 

In a letter sent to NIH Executive Director Maj Gen Dr Aamer Ikram, the general manager of China Sinopharm International Corp, Li Can, had expressed the hope that a successful clinical trial in Pakistan will make it one of the first few countries for the launch of a Covid-19 vaccine. 

The NIH official was then reported to have stated that although clearances were needed for the purpose, the collaboration could be a great thing for Pakistan. Meanwhile, researchers have said that Sinopharm’s coronavirus vaccine candidate appeared to be safe and triggered antibody-based immune responses in early and mid-stage trials. 

The candidate has already moved into a late-stage trial, one of a handful of candidates being tested on several thousand people to see if they are effective enough to win regulatory approval. 

Sinopharm is testing the potential vaccine in the United Arab Emirates (UAE) in a Phase 3 trial expected to recruit 15,000 people, as China has too few new cases to be a useful trial site. 

The shot did not cause any serious side effects, according to a paper published in the Journal of the American Medical Association (JAMA) by scientists who are part of Sinopharm and other China-based disease control authorities and research institutes. The results were based on data from 320 healthy adults in Phase 1 and 2 trials. 

Sinopharm’s chairman told state media last month that a potential vaccine could be ready by the end of this year with Phase 3 testing expected to be completed in about three months. 

The novel coronavirus, which has killed more than 750,000 people globally, has prompted a race to develop a vaccine. More than 150 candidate vaccines are being developed and tested around the world. China is leading the development of at least eight vaccine candidates in different stages of clinical trials.
Labels:

Comments

Post a Comment

Popular posts from this blog

KDSP: Empowering Individuals with Down Syndrome in Karachi

The Karachi Down Syndrome Program (KDSP), a beacon of hope and support, is making significant strides in empowering individuals with Down syndrome in the city. Founded in March 2014 by a group of passionate parents and individuals, KDSP addresses the critical need for comprehensive resources and platforms for those with Down syndrome in Karachi. Bridging the Gap: A Mission of Advocacy and Inclusion KDSP operates as a non-profit organization with a clear mission: to advocate for the value, acceptance, and inclusion of individuals with Down syndrome. Recognizing the limited support and resources available locally, KDSP was established to provide a nurturing environment where individuals with Down syndrome can lead independent and fulfilling lives. A Lifelong Journey of Support Understanding the unique needs of individuals with Down syndrome and their families, KDSP offers unwavering support from the moment a family receives a diagnosis.  They embark on a journey with each family, pro...
Post a Comment
Read more

Akbar Ali Khan elected AMUOBA President, appointed SSUET Chancellor

  By Abdul Qadir Qureshi (Pakistan News & Features Services) Akbar Ali Khan, son of the distinguished Engr Zakir Ali Khan, has been elected as the President of the Aligarh Muslim University Old Boys Association (AMUOBA), thereby assuming the position of Chancellor at Sir Syed University of Engineering and Technology (SSUET). He succeeds Jawaid Anwar as the university’s fourth Chancellor. SSUET was established in 1993 under the leadership of its founding Chancellor, Engr Z A Nizami. Following his passing in 2013, the role was subsequently held by Engr Adil Usman and Jawaid Anwar. Akbar Ali Khan now takes over this prestigious position, continuing his family’s legacy of service to the institution. The AMUOBA elections, held after a decade, witnessed the Zakir Ali Khan Panel securing victory over the Alig United Panel with a margin of 158 to 130 votes. Following his election, Akbar Ali Khan chaired the first Executive Committee meeting of AMUOBA, during which key office bearers we...
Post a Comment
Read more

Ambassador explains Chinese role in curbing COVID-19

By Masood Sattar Khan  (Pakistan News & Features Services) The Chinese Ambassador to Pakistan, Yao Jing, attended the preparation and response plan of the new crown epidemic on April 24. According to the details shared by the Chinese Embassy in Islamabad, Ambassador Yao Jing was invited to attend the Pakistan New Crown Outbreak Preparation and Response Plan (PPRP) on video conference. The meeting, organized by the Pakistani Ministry of Foreign Affairs, was also attended by Foreign Minister Shah Mahmood Qureshi, Minister of Economic Affairs, Khasro Bakhtiar, Prime Minister’s Health Adviser Dr Zafar Mirza, Chairman of the National Disaster Management Authority, General Muhammad Afzal, WHO Director-General, Tan Desai besides the representatives of World Bank, United Nations, UNICEF, UNHCR, Asian Development Bank, Islamic Development Bank and envoys from more than 20 countries.  Besides China, envoys from the United States, the United Kingdom, France, Canada, the European Unio...
Post a Comment
Read more